Induced-T Cell Like NK Cells for B Cell Malignancies

NCT04747093 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

12

Enrollment

OTHER

Sponsor class

Conditions

B Cell Leukemia
B Cell Lymphoma
B-cell Acute Lymphoblastic Leukemia
B-cell Lymphoma Recurrent
B-cell Lymphoma Refractory

Interventions

BIOLOGICAL: CAR-ITNK cells

Sponsor

Nanfang Hospital, Southern Medical University